Optimization of airway medications in the infant

Area of Science:

• Neonatal medicine
• Pediatric respiratory care
• Pharmacology in neonates

Background:

• Airway medications are integral to neonatal intensive care.
• Surfactant therapy for respiratory distress syndrome is a primary application.
• Other uses include managing bronchopulmonary dysplasia, pulmonary hypertension, and airway edema.

Purpose of the Study:

• To review current and potential applications of airway medications in neonates.
• To highlight areas requiring further investigation, such as bronchopulmonary dysplasia prevention.
• To provide an overview of non-surfactant airway medication uses.

Main Methods:

• Literature review of airway medication use in neonates.
• Discussion of established and emerging indications.
• Identification of ongoing clinical trials and research needs.

Main Results:

• Established use of surfactant for respiratory distress syndrome.
• Investigational use for prevention of bronchopulmonary dysplasia.
• Exploration of treatments for pulmonary hypertension, atelectasis, transient tachypnea, and edema.

Conclusions:

• Airway medications serve diverse roles in neonatal respiratory care.
• Prevention of bronchopulmonary dysplasia is a key area of ongoing research.
• Further studies are essential to optimize the use of these critical therapies.